The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
Open accessAbstract
Endocytosis of the Flaviviridae viruses, hepatitis C virus, GB virus C/hepatitis G virus, and bovine viral diarrheal virus (BVDV) was shown to be mediated by low density lipoprotein (LDL) receptors on cultured cells by several lines of evidence: by the demonstration that endocytosis of these virus correlated with LDL receptor activity, by complete inhibition of detectable endocytosis by anti-LDL receptor antibody, by inhibition with anti-apolipoprotein E and -apolipoprotein B antibodies, by chemical methods abrogating lipoprotein/LDL receptor interactions, and by inhibition with the endocytosis inhibitor phenylarsine oxide. Confirmatory evidence was provided by the lack of detectable LDL receptor on cells known to be resistant to BVDV infection. Endocytosis via the LDL receptor was shown to be mediated by complexing of the virus to very low density lipoprotein or LDL but not high density lipoprotein. Studies using LDL receptor-deficient cells or a cytolytic BVDV system indicated that the LDL receptor may be the main but not exclusive means of cell entry of these viruses. Studies on other types of viruses indicated that this mechanism may not be exclusive to Flaviviridae but may be used by viruses that associate with lipoprotein in the blood. These findings provide evidence that the family of LDL receptors may serve as viral receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Knowles, B. B., Howe, C. C., & Aden, D. P. (1980) · Science · doi:10.1126/science.6248960 · Cited by 2,025
Pellerin, C., Van Den Hurk, J., Lecomte, J., & Tijssen, P. (1994) · Virology · doi:10.1006/viro.1994.1483 · Cited by 533
Hofer, F., Gruenberger, M., Kowalski, H., Machat, H., Huettinger, M., Kuechler, E., & Blass, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1839 · Cited by 465
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Association of hepatitis C virus in human sera with ?-lipoprotein
Thomssen, R., Bonk, S., Propfe, C., Heermann, K.-H., K�chel, H. G., & Uy, A. (1992) · Medical Microbiology and Immunology · doi:10.1007/bf00198849 · Cited by 366
A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor
Bates, P., Young, J. A. T., & Varmus, H. E. (1993) · Cell · doi:10.1016/0092-8674(93)90726-7 · Cited by 355
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus
Monazahian, M., B�hme, I., Bonk, S., Koch, A., Scholz, C., Grethe, S., & Thomssen, R. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199903)57:3<223::aid-jmv2>3.0.co;2-4 · Cited by 349
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
Weisgraber, K. H., Innerarity, T. L., Harder, K. J., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44181-0 · Cited by 220
Receptor-mediated low density lipoprotein catabolism in man.
Shepherd, J., Bicker, S., Lorimer, A. R., & Packard, C. J. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40002-1 · Cited by 182
Lipoprotein analysis; a practical approach
(1993) · International Journal of Biochemistry · doi:10.1016/0020-711x(93)90253-b · Cited by 158
Induction of circulating IL-1 receptor antagonist by IFN treatment
Tilg, H., Mier, J. W., Vogel, W., Aulitzky, W. E., Wiedermann, C. J., Vannier, E. G., Huber, C. H., & Dinarello, C. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.10.4687 · Cited by 136
Pease, R. J., Milne, R. W., Jessup, W., Law, A., Provost, P. R., Fruchart, J., Dean, R. T., Marcel, Y. L., & Scott, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40266-4 · Cited by 127
Viral contamination of bovine foetal serum and cell cultures
NUTTALL, P. A., LUTHER, P. D., & Stott, E. J. (1977) · Nature · doi:10.1038/266835a0 · Cited by 115
Establishment of persistent hepatitis C virus infection and replication in vitro.
Seipp, S., Lorenz Theilmann, I., Goeser, T., Mueller, H. M., Pfaff, E., & Stremmel, W. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-10-2467 · Cited by 111
Detection of widespread hepatocyte infection in chronic hepatitis C
Agnello, V., Ábel, G., Knight, G. B., & Muchmore, E. (1998) · Hepatology · doi:10.1002/hep.510280240 · Cited by 99
Self-citationMarcel, Y. L., Provost, P. R., Koa, H., Raffaï, E., Vu‐Dac, N., Fruchart, J., & Rassart, É. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67843-9 · Cited by 94
An Antiviral Soluble Form of the LDL Receptor Induced by Interferon
Fischer, D. G., Tal, N., Novick, D., Barak, S., & Rubinstein, M. (1993) · Science · doi:10.1126/science.8211145 · Cited by 63
Yanagi, M., Bukh, J., Emerson, S. U., & Purcell, R. H. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1324 · Cited by 45
Ranganathan, S., Hattori, H., & Kashyap, M. L. (1995) · PubMed · Cited by 30
Lipoprotein - receptor interactions
Arnold, K. S., Innerarity, T. L., Pitas, R. E., & Mahley, R. W. (1992) · doi:10.1093/oso/9780199631926.003.0006 · Cited by 21
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Cohen, J., Pertsemlidis, A., Kotowski, I. K., Graham, R., Garcia, C. K., & Hobbs, H. H. (2005) · Nature Genetics · doi:10.1038/ng1509 · Cited by 1,381
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Bartosch, B., Dubuisson, J., & Cosset, F.-L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021756 · Cited by 1,111
Metadata
- Authors
- Agnello, V., Ábel, G., Elfahal, M., Knight, G. B., & Zhang, Q.-X.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-10-26
- Volume
- 96
- Issue
- 22
- Pages
- 12766-12771
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1986505810
- Cited by
- 974
- References
- 21
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.